Karmarts Valuation
Is KAMART-R undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of KAMART-R when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: KAMART-R (THB15.6) is trading above our estimate of fair value (THB4.21)
Significantly Below Fair Value: KAMART-R is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for KAMART-R?
Other financial metrics that can be useful for relative valuation.
What is KAMART-R's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | ฿17.16b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 6.5x |
Enterprise Value/EBITDA | 22.4x |
PEG Ratio | n/a |
Price to Earnings Ratio vs Peers
How does KAMART-R's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 34.8x | ||
S&J S & J International Enterprises | 10.6x | n/a | ฿7.6b |
IP Inter Pharma | 73x | 58.9% | ฿3.7b |
KISS Rojukiss International | 27.6x | 14.1% | ฿3.6b |
APCO Asian Phytoceuticals | 27.9x | n/a | ฿3.0b |
KAMART-R Karmarts | 26x | n/a | ฿17.2b |
Price-To-Earnings vs Peers: KAMART-R is good value based on its Price-To-Earnings Ratio (26x) compared to the peer average (34.8x).
Price to Earnings Ratio vs Industry
How does KAMART-R's PE Ratio compare vs other companies in the Asian Personal Products Industry?
Price-To-Earnings vs Industry: KAMART-R is expensive based on its Price-To-Earnings Ratio (26x) compared to the Asian Personal Products industry average (24.2x).
Price to Earnings Ratio vs Fair Ratio
What is KAMART-R's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 26x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate KAMART-R's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.